BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 27489271)

  • 1. Serine/Arginine-Rich Splicing Factor 3 and Heterogeneous Nuclear Ribonucleoprotein A1 Regulate Alternative RNA Splicing and Gene Expression of Human Papillomavirus 18 through Two Functionally Distinguishable cis Elements.
    Ajiro M; Tang S; Doorbar J; Zheng ZM
    J Virol; 2016 Oct; 90(20):9138-52. PubMed ID: 27489271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region.
    Zheng Y; Jönsson J; Hao C; Shoja Chaghervand S; Cui X; Kajitani N; Gong L; Wu C; Schwartz S
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32759322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    McFarlane M; MacDonald AI; Stevenson A; Graham SV
    J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene.
    Zhao X; Rush M; Schwartz S
    J Virol; 2004 Oct; 78(20):10888-905. PubMed ID: 15452209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-Wide Analysis of Heterogeneous Nuclear Ribonucleoprotein (hnRNP) Binding to HIV-1 RNA Reveals a Key Role for hnRNP H1 in Alternative Viral mRNA Splicing.
    Kutluay SB; Emery A; Penumutchu SR; Townsend D; Tenneti K; Madison MK; Stukenbroeker AM; Powell C; Jannain D; Tolbert BS; Swanstrom RI; Bieniasz PD
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31413137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure.
    Damgaard CK; Tange TO; Kjems J
    RNA; 2002 Nov; 8(11):1401-15. PubMed ID: 12458794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E6^E7, a novel splice isoform protein of human papillomavirus 16, stabilizes viral E6 and E7 oncoproteins via HSP90 and GRP78.
    Ajiro M; Zheng ZM
    mBio; 2015 Feb; 6(1):e02068-14. PubMed ID: 25691589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing.
    Kashima T; Rao N; David CJ; Manley JL
    Hum Mol Genet; 2007 Dec; 16(24):3149-59. PubMed ID: 17884807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding.
    Marchand V; Méreau A; Jacquenet S; Thomas D; Mougin A; Gattoni R; Stévenin J; Branlant C
    J Mol Biol; 2002 Nov; 323(4):629-52. PubMed ID: 12419255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.
    Tange TO; Damgaard CK; Guth S; Valcárcel J; Kjems J
    EMBO J; 2001 Oct; 20(20):5748-58. PubMed ID: 11598017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV18 Utilizes Two Alternative Branch Sites for E6*I Splicing to Produce E7 Protein.
    Brant AC; Majerciak V; Moreira MAM; Zheng ZM
    Virol Sin; 2019 Apr; 34(2):211-221. PubMed ID: 30945125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eight nucleotide substitutions inhibit splicing to HPV-16 3'-splice site SA3358 and reduce the efficiency by which HPV-16 increases the life span of primary human keratinocytes.
    Li X; Johansson C; Cardoso Palacios C; Mossberg A; Dhanjal S; Bergvall M; Schwartz S
    PLoS One; 2013; 8(9):e72776. PubMed ID: 24039800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cells.
    Guo R; Li Y; Ning J; Sun D; Lin L; Liu X
    PLoS One; 2013; 8(4):e62729. PubMed ID: 23658645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins.
    Zhu J; Mayeda A; Krainer AR
    Mol Cell; 2001 Dec; 8(6):1351-61. PubMed ID: 11779509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Papillomavirus E2 Regulates SRSF3 (SRp20) To Promote Capsid Protein Expression in Infected Differentiated Keratinocytes.
    Klymenko T; Hernandez-Lopez H; MacDonald AI; Bodily JM; Graham SV
    J Virol; 2016 May; 90(10):5047-58. PubMed ID: 26962216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of hnRNP A1, SR proteins, and p68 helicase in c-H-ras alternative splicing regulation.
    Guil S; Gattoni R; Carrascal M; Abián J; Stévenin J; Bach-Elias M
    Mol Cell Biol; 2003 Apr; 23(8):2927-41. PubMed ID: 12665590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.
    Mayeda A; Helfman DM; Krainer AR
    Mol Cell Biol; 1993 May; 13(5):2993-3001. PubMed ID: 8474457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple ASF/SF2 sites in the human papillomavirus type 16 (HPV-16) E4-coding region promote splicing to the most commonly used 3'-splice site on the HPV-16 genome.
    Somberg M; Schwartz S
    J Virol; 2010 Aug; 84(16):8219-30. PubMed ID: 20519389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a 17-nucleotide splicing enhancer in HPV-16 L1 that counteracts the effect of multiple hnRNP A1-binding splicing silencers.
    Zhao X; Fay J; Lambkin H; Schwartz S
    Virology; 2007 Dec; 369(2):351-63. PubMed ID: 17869320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: implications for pre-mRNA processing.
    Zerbe LK; Pino I; Pio R; Cosper PF; Dwyer-Nield LD; Meyer AM; Port JD; Montuenga LM; Malkinson AM
    Mol Carcinog; 2004 Dec; 41(4):187-96. PubMed ID: 15390079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.